SWP
ACHV icon

Stratos Wealth Partners’s Achieve Life Sciences ACHV Stock Holding History

Stratos Wealth Partners’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1
Closed – – 979
2018
Q1 		$0 Buy
+1
New +$286 ﹤0.01% 3103

Other funds holding ACHV

WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Stratos Wealth Partners's ACHV Position: Q2 2018 in Review

Stratos Wealth Partners sold out of Achieve Life Sciences (ACHV) in Q2 2018, closing a stake of 1 share.

Stratos Wealth Partners first reported a position in ACHV in Q1 2018 and held it in 1 quarter. The position peaked at $0 in Q1 2018. 15 funds tracked by Wall St. Rank hold ACHV as of Q2 2018.

  • Stratos Wealth Partners reported no remaining Achieve Life Sciences position as of Q2 2018 after selling out during the quarter.
  • Stratos Wealth Partners sold 1 Achieve Life Sciences share in Q2 2018.
  • Stratos Wealth Partners first reported a position in Achieve Life Sciences in Q1 2018 and held it in 1 quarter.
  • Stratos Wealth Partners's Achieve Life Sciences position peaked at $0 in Q1 2018.
  • 15 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2018.

Based on Stratos Wealth Partners's 13F filing for Q2 2018, filed 13 Aug 2018.